FDA Prioritizing Review of New Drug Application for MDMA-Assisted Therapy
The FDA has granted priority review status for Lykos Therapeutics' new drug application for MDMA therapy. Read more here!
Please explore some excellent written blogs by members of The Pearl Psychedelic Institute including our Executive and Clinical Director, Dr. Raymond Turpin. Dr. Turpin also serves as Co-Principal Investigator and Co-Lead Therapist for The Pearl MDMA Project.
"Climb the mountains and get their good tidings. Nature's peace will flow into you as sunshine flows into trees. The winds will blow their own freshness into you, and the storms their energy, while cares will drop off like autumn leaves."
John Muir